Yahoo Finance • 3 days ago
Insulet Corp (NASDAQ:PODD [https://www.chartmill.com/stock/quote/PODD]) has been recognized as a possible option for investors focused on high-growth momentum, applying Mark Minervini’s Trend Template strategy. This method blends strict te... Full story
Yahoo Finance • 4 days ago
In the stock market today, the Dow Jones index trimmed losses made after a PPI inflation report. Coherent plunged on earnings. Bullish rose 10%. Continue Reading View Comments... Full story
Yahoo Finance • 4 days ago
Stock Market Today: The Dow Jones index dropped mildly on a hot PPI inflation report as the Nasdaq trimmed losses. Coherent stock plunged after its earnings report included a disappointing forecast. Continue Reading View Comments... Full story
Yahoo Finance • 10 days ago
(RTTNews) - Insulet Corp. (PODD) released a profit for second quarter that Decreased from the same period last year but beat the Street estimates. The company's bottom line came in at $22.50 million, or $0.32 per share. This compares wi... Full story
Yahoo Finance • 11 days ago
INSULET CORP. (NASDAQ:PODD) REPORTS STRONG Q2 2025 EARNINGS, BEATS REVENUE AND EPS ESTIMATES Insulet Corp. (NASDAQ:PODD [https://www.chartmill.com/stock/quote/PODD]) delivered robust second-quarter results, surpassing analyst expectations... Full story
Yahoo Finance • 16 days ago
Below is Validea's guru fundamental report for INSULET CORP (PODD). Of the 22 guru strategies we follow, PODD rates highest using our Twin Momentum Investor model based on the published strategy of Dashan Huang. This momentum model looks... Full story
Yahoo Finance • last month
Semler Scientific shows improving price performance, earning an upgrade to its IBD Relative Strength Rating from 68 to 82. Continue Reading View Comments... Full story
Yahoo Finance • 2 months ago
Shares of Dexcom, Tandem Diabetes and Insulet skidded Tuesday on a proposal that would cut Medicare reimbursements for wearable diabetes tech. Continue Reading View Comments... Full story
Yahoo Finance • 2 months ago
Yahoo Finance anchor Brad Smith examines some of the top headlines on Wall Street as part of today's Market Minute. Apple (AAPL) is reportedly considering using an external artificial intelligence (AI) language learning model (LLM) for Si... Full story
Yahoo Finance • 2 months ago
Check out the companies making the biggest moves midday: Diabetes tech stocks — The Centers for Medicare & Medicaid Services is proposing a rule change that could change the reimbursement rates for continuous glucose monitors and insulin p... Full story
Yahoo Finance • 2 months ago
Key Points The healthcare sector offers an abundance of high-growth investment opportunities. Companies leveraging artificial intelligence and genomic medicine are delivering innovative therapies with significant potential. Small-cap and... Full story
Yahoo Finance • 2 months ago
Sarah Karlin-Smith of Pink Sheet reported via X: “RFK says HHS about to launch one of the biggest campaigns in HHS history to encourage Americans to use wearable health devices (like CGMs). His vision is every American wearing “wearable” i... Full story
Yahoo Finance • 2 months ago
Investing.com-- Shares of U.S. medical device companies climbed sharply on Tuesday, boosted by Health Secretary Robert F. Kennedy Jr.’s strong endorsement of wearables during congressional testimony. Kennedy announced a new “Make America... Full story
Yahoo Finance • 2 months ago
Insulet Corporation insulin monitor-by Maria Wan via Shutterstock Insulet Corporation (PODD), headquartered in Acton, Massachusetts, operates as an innovative medical device company. Valued at $21.3 billion by market cap, the company deve... Full story
Yahoo Finance • 2 months ago
Below is Validea's guru fundamental report for INSULET CORP (PODD). Of the 22 guru strategies we follow, PODD rates highest using our Twin Momentum Investor model based on the published strategy of Dashan Huang. This momentum model looks... Full story
Yahoo Finance • 2 months ago
Presentations and panel discussions to provide deeper dives into the clinical outcomes from Insulet’s groundbreaking SECURE-T2D and RADIANT trialsReal-world evidence around glycemic outcomes from more than 23,000 people with type 2 diabete... Full story
Yahoo Finance • 2 months ago
Presentations and panel discussions to provide deeper dives into the clinical outcomes from Insulet’s groundbreaking SECURE-T2D and RADIANT trials Real-world evidence around glycemic outcomes from more than 23,000 people with type 2 diabet... Full story
Yahoo Finance • 2 months ago
The most talked about and market moving research calls around Wall Street are now in one place. Here are today’s research calls that investors need to know, as compiled by The Fly. Confident Investing Starts Here: Easily unpack a company... Full story
Yahoo Finance • 2 months ago
PALM BEACH, Fla., June 17, 2025 (GLOBE NEWSWIRE) -- FN Media Group News Commentary - The global diabetic retinopathy market has shown a consistent growth in recent years and is expected to continue for the coming several years. According... Full story
Yahoo Finance • 2 months ago
Insulet Corporation (NASDAQ:PODD), a pioneer in the insulin pump market with a substantial market capitalization of $21.58 billion, has been making waves in the medical technology sector with its innovative Omnipod 5 platform. The company’... Full story